Free tool
Healthcare stocks
We cover 70 companies in the Healthcare sector. The median market value in the group is $494.52M. Across the group, the median move over the past trading day is 0.00%. 42% of the 65 with a 200-day average trade above it. Price change over the past year runs from −57.4% to +40.9% across the middle 80 percent of the group, with a median of −8.8%.
Other lists in this group
Table
70 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% | Sep 1, 2026 |
| SIG.AX | Sigma Healthcare Limited | 2.59 AUD | −13.09% | −11.26% | −15.21% | Aug 27, 2026 |
| COO | The Cooper Companies, Inc. | $72.68 | +0.86% | −10.39% | −1.93% | Sep 9, 2026 |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% | Sep 21, 2026 |
| ABVX | ABIVAX Société Anonyme | $116.52 | −6.21% | −12.90% | +46.70% | Sep 21, 2026 |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% | Aug 27, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% | Sep 1, 2026 |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% | Aug 27, 2026 |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% | Sep 17, 2026 |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% | Sep 23, 2026 |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% | Aug 27, 2026 |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% | Aug 27, 2026 |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% | Aug 27, 2026 |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% | Sep 10, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% | Sep 14, 2026 |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% | Sep 10, 2026 |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% | Sep 8, 2026 |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% | Sep 14, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| SNZ.AX | Summerset Group Holdings Limited | 7.00 AUD | −0.14% | −32.73% | −26.63% | Aug 27, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| IVA.PA | Inventiva S.A. | 4.09 EUR | +3.94% | +0.99% | −14.63% | Sep 25, 2026 |
| IVA | Inventiva S.A. | $4.82 | +3.88% | +1.26% | −7.84% | Sep 25, 2026 |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% | Aug 27, 2026 |
| VETO.PA | Vetoquinol SA | 70.60 EUR | −3.29% | −16.35% | −6.37% | Sep 11, 2026 |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% | Sep 23, 2026 |
| PHR | Phreesia, Inc. | $11.60 | +6.81% | −28.83% | −63.74% | Sep 2, 2026 |
| 4592.T | SanBio Company Limited | 997.00 JPY | +10.78% | −39.10% | −57.08% | Sep 14, 2026 |
| REG1V.HE | Revenio Group Oyj | 14.78 EUR | +16.56% | −33.12% | −38.54% | Sep 8, 2026 |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% | Sep 22, 2026 |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% | Aug 27, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| CUV.AX | Clinuvel Pharmaceuticals Limited | 9.36 AUD | −2.40% | −26.36% | −24.94% | Aug 27, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | 1.78 EUR | +12.80% | +12.80% | −2.52% | Sep 17, 2026 |
| SY | So-Young International Inc. | $2.40 | +22.45% | −10.11% | −38.93% | Aug 31, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% | Sep 14, 2026 |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% | Aug 27, 2026 |
| ALCGM.PA | Cegedim SA | 10.26 EUR | +1.38% | −25.92% | −4.56% | Sep 24, 2026 |
| BINV.ST | BioInvent International AB (publ) | 24.30 SEK | +5.42% | −17.21% | −23.46% | Aug 27, 2026 |
| ENGN | enGene Therapeutics Inc. | $1.95 | +10.80% | −77.97% | −55.07% | Sep 14, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| NNOX | Nano-X Imaging Ltd. | $0.88 | −0.25% | −69.05% | −77.77% | Sep 9, 2026 |
| CSBR | Champions Oncology, Inc. | $4.92 | −11.03% | −26.13% | −25.45% | Sep 14, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% | Aug 27, 2026 |
| HYFT | MindWalk Holdings Corp. | $1.43 | +5.15% | −29.21% | −46.04% | Sep 14, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | 7.78 NOK | −11.59% | −22.04% | −4.19% | Aug 27, 2026 |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% | Sep 2, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% | Aug 28, 2026 |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% | Aug 27, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.08 EUR | +14.41% | −2.99% | −27.68% | Sep 10, 2026 |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −42.11% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | 3.55 NOK | +3.20% | −14.46% | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | 1.03 EUR | +0.39% | −11.21% | −19.22% | Sep 15, 2026 |
| BLRX | BioLineRx Ltd. | $2.70 | −3.91% | −3.57% | −26.63% | Aug 31, 2026 |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% | Sep 23, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $0.31 | −6.25% | −79.22% | −89.43% | Aug 27, 2026 |
| 0VQ.DE | PureTech Health plc | 1.35 EUR | 0.00% | −12.90% | +1.50% | Aug 27, 2026 |
| 6IV.DE | Inventiva S.A. | 4.08 EUR | +3.68% | +0.87% | −33.03% | Sep 25, 2026 |
| ADXN.SW | Addex Therapeutics Ltd | 0.03 CHF | −37.38% | −51.32% | −55.21% | Sep 14, 2026 |
| GXI.SW | Gerresheimer AG | 25.28 CHF | −1.71% | +2.10% | +2.10% | Aug 27, 2026 |
| MOVE.SW | Medacta Group SA | 127.40 CHF | −7.55% | −18.95% | −10.60% | Sep 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.